INTRODUCTION
Okadaic acid (C44H66013) is a monocarboxylic acid extracted from common black sponges of the genus Halichondria. The chemical structure has been determined by Tachibana et al. (1981) . Recently we reported that micromolar concentrations ofthis substance strongly inhibit the phosphorylated myosin light-chain (PMLC) phosphatase activity of smooth-muscle extract Bialojan et al., 1987 Bialojan et al., , 1988 . Okadaic acid similarly inhibited a purified polycation-modulated (PCM) phosphatase from bovine aorta (DiSalvo et al., 1984) . So far, two endogenous phosphatase inhibitors, termed inhibitor 1 and inhibitor 2, have been isolated (Huang & Glinsmann, 1976) . According to Cohen's classification (Ingebritsen & Cohen, 1983) , our PCM phosphatase is a type 2 phosphatase, since it is not affected by these endogenous inhibitors (DiSalvo et al., 1984) . To our knowledge, okadaic acid is the first substance that has been shown to inhibit type 2 phosphatase in micromolar concentrations. Besides inhibitor 1 and inhibitor 2, only rather non-specific phosphatase inhibitors such as NaF (Morgan et al., 1976) or vanadate (Searle, 1983) Cummins & Lambert (1986) . Myosin light-chain kinase was purifed from chicken gizzards as described by Ngai et al. (1984) . Phosphorylase b and phosphorylase kinase from rabbit skeletal muscle as well as acid phosphatase and alkaline phosphatase were obtained from Sigma Chemical Co. Calmodulin from pig brain was purchased from Boehringer Mannheim. Calcineurin (= type 2B phosphatase; Klee & Krinks, 1978; Stewart et al., 1982) (Tung et al., 1984) as well as type 2C phosphatase from rabbit liver (McGowan & Cohen, 1987) were generously given by Dr. G. Mieskes, G6ttingen, Germany. Aortic PCM phosphatase was purified as described previously (DiSalvo et al., 1984) , involving chromatography on DEAE-Sephacel, polylysine-agarose, heparin-agarose and a Mono Q Vol. 256
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HR 5/5 anion-exchange column with the Pharmacia f.p.l.c. system. SDS/polyacrylamide-gel electrophoresis of the purified enzyme revealed three polypeptides corresponding to 72, 53 and 35 kDa, confirming the previous report (DiSalvo et al., 1985) . According to Cohen's classification of protein phosphatases (Ingebritsen & Cohen, 1983) this PCM phosphatase is a type 2A phosphatase because it is not affected by inhibitor 1 or inhibitor 2 (DiSalvo et al., 1984) and has a 5-fold higher PMLC phosphatase activity than phosphorylase a phosphatase activity (see the Results section).
Enzyme assays All enzymes were tested at 30 'C. The assays were made in a buffer containing 20 mM-Tris/HCl, 0.5 mMdithiothreitol and 1 mg of bovine serum albumin/ml, pH 7.4. The reaction mixtures for the assays of phosphorylase a phosphatase activity contained 5 mM-caffeine in addition. For standard assays, either 32P-labelled PMLC or 32P-labelled phosphorylase a was used as substrate. Reactions were started by injecting the 32P-labelled substrate into the reaction mixture, and stopped by addition of ice-cold trichloroacetic acid (20 %, w/v) and 6 mg of bovine serum albumin/ml. Assessment of released Pi was performed by standard procedures (DiSalvo et al., 1982) . The enzyme activity of type 1 phosphatase was measured in buffer containing 2 mMMnCl2. For the assay of type 2C phosphatase 11 mmmagnesium acetate was included in the buffer. The activity of calcineurin was measured with either pnitrophenyl phosphate or PMLC as substrate. The reaction mixtures contained 40 mM-Tris/HCl, 0.1 M-KCI, 0.1 mg of bovine serum albumin/ml, 6 mM-MgCl2, 0.25 mM-dithiothreitol, 0.1 sM-calmodulin and 0.1 mmCaCl2, pH 8.0. p-Nitrophenyl phosphate phosphatase activity of calcineurin was measured by recording the initial rate of increase in absorbance at 400 nm.
In the dose-inhibition analyses, the concentration of enzymes was such that less than 5 % of the radioactive substrate was consumed during the reaction time of 3-10 min. The consumption of p-nitrophenyl phosphate was less than 1 % of the initial concentration. In the enzyme-kinetic studies, we allowed consumption of the substrate to a maximum of 15 % of the initial concentration, so as to make the measurements at the lower substrate concentration range sufficiently accurate. [3H]inositol trisphosphate, and the initial rate of breakdown ofinositol trisphosphate was measured as described by Walker et al. (1987) .
Okadaic acid was dissolved in pure dimethyl sulphoxide and added to the experimental solution. Control solutions contained the same concentration (0.5%, v/v) of dimethyl sulphoxide.
Protein was measured by the method of Lowry et al. (1951) .
Analysis of kinetic data
When an enzyme reaction is monitored over an extended time, the velocity of the reaction progressively slows down as a result of depletion of substrate and accumulation of product. In the present experiments, accumulation of product was limited, so that its effect on the reaction velocity could be neglected (see above). The slowing down resulting from depletion of substrate was corrected for by the following mathematical procedure. Because of depletion of substrate, v(s) < v(s). We define the correction factor,f, by the following equation:
Inserting eqns. (1) and (2) into eqn. (3), and rearranging, we have:
The integrated form of eqn. (1) is:
(see Cornish-Bowden, 1977; Dixon & Webb, 1979) .
Eliminating V-t in eqn. (4) by eqn. (5), and rearranging, we obtain:
95 % confidence limits. The other numerical data were described as means + S.E.M., and differences were assessed by the Student's t test. The dose-inhibition relations were fitted by the linear least-squares method to the linear form of the Hill function:
ln[(100-E)/EJ = h*lnI+lnK where p = [s-s(t)]/s. The enzyme-kinetic results presented have been corrected for substrate depletion by using this correction factor (see also eqn. 3). As for the present data, the values of f were not less than 0.9, i.e. 0.9 <f < 1. Dose-inhibition relation In the following description, the apparent values of Km and V in the presence of inhibitor (okadaic acid) are denoted as Km' and V' respectively.
In general, the concentration of inhibitor required to obtain 50 % inhibition (ID50) is a function of substrate concentration. This fact is important when the values of ID50 are compared. The function can be mathematically derived if the dependence of initial steady-state velocity on the substrate concentration is described in the form of the Michaelis-Menten equation both in the absence and in the presence of inhibitor, and if the dose-inhibition relation is given in the form of the Hill function (see Bialojan et al., 1988) . The following equations are relevant to the present results. 
(ii) When Kin = Km and V' < V (non-competitive inhibition): ID50 = K1 = K2 (constant)
(see eqns. 7, 8 and 9).
The results presented have been corrected for a higher extent of substrate utilization at lower inhibitor concentrations by using the correction factor described above (see eqns. 3 and 6). (Eisenthal & Cornish-Bowden, 1974) , and evaluation of their difference by a non-parametric method (Hollander & Wolfe, 1973) where E is the percentage enzyme activity, I is the concentration of inhibitor, h is the Hill coefficient and KA is the association constant. The values in the range 10% < E < 90 % were used for the fitting. The values of ID50 and Hill coefficient were compared by a method of co-variance analysis (Snedecor & Cochran, 1980) . Very similar values of ID50 and Hill coefficient were obtained when the fitting was made by a non-linear least-squares method (Snedecor & Cochran, 1980) . In every case, differences were evaluated as statistically significant when a two-sided probability of less than 0.05 was obtained. Table  1 ). The values of ID50 and Hill coefficient are given in Table 1 dose-inhibition relations were also examined for their phosphorylase a phosphatase activity (Fig. lb) . Parameters of the inhibition curves are given in Table 1 The experiments are similar to those illustrated in Fig. 3 . The PMLC phosphatase activity (a) and phosphorylase a phosphatase activity (b) of PCM phosphatase were measured. 0, Control; *, okadaic acid (a, 300 nM; b, 100 nM).
RESULTS

Dose-inhibition relations
The values are normalized to the kinetic constants determined by the direct-linear-plot method ( As for phosphatase 2B, the effect of okadaic acid was also tested for its p-nitrophenyl phosphate phosphatase activity in Tris buffer, pH 8.0 (Fig. 2) . The control activity (Table 1) 2A, phosphatase (catalytic subunit of the skeletal-muscle type 2A phosphatase) the double-reciprocal plots were linear over the substrate concentration range for both PMLC phosphatase activity and phosphorylase a phosphatase activity of the enzyme. For the PMLC phosphatase activity the values of Km and V were estimated, as described in the Experimental section, to be 3.8,UM and 17200 units/mg of protein respectively (Table 2 ). These were significantly changed to 12 mm (= Km'; P < 0.008) and 8550 units/mg of protein (= V'; P < 0.016) by 5 nmokadaic acid, indicating that okadaic acid acts as a mixed inhibitor. From the values of V'/V (0.50) and Km'/Km (3.2), the upper and lower limits of the change of ID50
produced by changing the substrate concentration were estimated, by using eqns. (8) and (9), to be 5 nM (= K1) and 0.7 nm (= K2) respectively.
For the phosphorylase a phosphatase activity the Km was 8.2-fold larger whereas the V was 2.3-fold smaller than those for the PMLC phosphatase activity (Table 2) . This qualitatively agrees with the previous report by Ingebritsen & Cohen (1983) . Okadaic acid (2 nM) significantly decreased the value of V whereas it did not affect the value of Km, i.e. the inhibition was non-competitive.
As expected from eqn. (10), the value of ID50 of the dose-inhibition relation was not altered when the substrate concentration was changed from 10 /M to 2 UM and 20,u/M. PCM phosphatase. When PMLC was used as substrate, the double-reciprocal plot was linear over the concentration range (0.5-10/tM) of PMLC examined (Fig. 4a) . Both Km and V were significantly (P < 0.002) changed by 300 nM-okadaic acid ( Table 2 ), indicating that okadaic acid acts as a mixed inhibitor. From the change of the kinetic constants, the lower and upper limits of the variation of ID50 produced by changing the substrate concentration were estimated, by using eqns. (7) and (8), to be 60 nm and 460 nm respectively. For the phosphorylase a phosphatase activity of PCM phosphatase the double-reciprocal plot had two components (Fig. 4b) , one below and one above a substrate concentration of about 8 /LM (Km/[phosphorylase a] = 0.14-0.18). The values of Km and V above 8 /M substrate were both significantly different (P < 0.002) from those below this critical concentration. In the lower substrate concentration range (0.5-5 /tM) both Km and V were changed by 100 nM-okadaic acid (P < 0.002), i.e. the inhibition was a mixed type. In the higher concentration range (10-80 ,uM) V was decreased (P < 0.002) whereas Km was not significantly changed by okadaic acid, i.e. the inhibition was a non-competitive type. As a consequence the dependence of ID50 on the substrate concentration was somewhat complicated (Fig. 6 ). In the range 0.5- See Table 2 for the kinetic constants. See the text for further explanation. Type 2B PMLC 0.5-5 5000 6.5 (3.4-9.3) 2.1 (1.1-2.6) phosphorylase a concentration was increased, whereas it abruptly decreased to a constant value when the phosphorylase a concentration exceeded 8^M as expected from eqn. (10) (K1 = K2 = 64 nM). At the critical concentration (8-10 ,lM) the co-variance analysis of the dose-inhibition relation gave a significantly larger residual variance (P < 0.01) than for both sides of this concentration.
[Note the relatively large S.E.M. values in the dose-response relation for this enzyme activity (Fig.  lb) .] The range ofvariation of ID50 produced by changing substrate concentration was estimated to be 50-100 nm (Fig. 6 ). This falls within the variation range of ID50 estimated for the PMLC phosphatase activity of the enzyme (see above).
The control value of V was 5.4-fold higher for the PMLC phosphatase activity than for the phosphorylase a phosphatase activity of the enzyme (Table 2 ). In this respect the substrate specificity of our PCM phosphatase has a similarity to that of type 2A phosphatase (cf. Ingebritsen & Cohen, 1983) .
Type 1 phosphatase and calcineurin. For these types of enzyme, kinetic studies were made with PMLC as substrate (Fig. 5) . The values of Km were one order of magnitude larger whereas the values of V expressed in terms of the specific activity were considerably smaller than those of the PMLC phosphatase activity of PCM phosphatase (Table 2 ). In the range of substrate concen- of the dose-inhibition relation were plotted against the concentration of phosphorylase a. The curve and horizontal line show the relation expected from eqns. (7) and (10) (see the Experimental section); the kinetic constants for the lower and higher concentration ranges of phosphorylase a given in Table 2 were used for computation. The Hill coefficient (h = 0.96-0.98) was not significantly changed when the substrate concentration was varied. See the text for further detail.
trations examined the inhibition was non-competitive for both enzymes; okadaic acid changed only the values of V(P < 0.02). In accordance with eqn. (10), we found that the values of ID50 of the dose-inhibition relations were not significantly altered when the substrate concentration was changed from 4 m to 1 /SM and 10 /LM.
Effect on other phosphatases Neither cytosolic nor particulate-bound inositol trisphosphate phosphatase from smooth muscle was inhibited by up to 50 #uM-okadaic acid. No effect was found with tyrosine-specific phosphatase(s) from cell lysates. Alkaline phosphatases (from bovine intestinal mucosa and pig placenta) and acid phosphatases (from milk and potato) tested with p-nitrophenyl phosphate as substrate were not affected by 10 1tM-okadaic acid. However, a three-subunit phosphatase isolated from dog heart (Kranias & DiSalvo, 1986) was strongly inhibited by okadaic acid (E. G. Kranias & J. DiSalvo, personal communication) . The enzyme expressed phosphatase activity against phospholamban and phosphorylase a; both activities were completely inhibited by okadaic acid in micromolar concentration.
DISCUSSION
In previous papers we have reported that micromolar concentrations of okadaic acid potently inhibit the PMLC phosphatase activity of smooth-muscle extract and of the aortic PCM phosphatase Bialojan et al., 1987 Bialojan et al., , 1988 phosphatase, acid phosphatases and alkaline phosphatases (the present work). We have also shown that okadaic acid does not affect the Ca2+ + calmodulindependent activity of myosin light-chain kinase or phosphodiesterase . Thus the inhibitory action of okadaic acid appears to be specific for some restricted types of protein phosphatase.
The type of substrate has little effect on the inhibitory action ofokadaic acid. Essentially similar dose-inhibition relations are obtained for the PMLC phosphatase activity and the phosphorylase a phosphatase activity of type 2A., PCM and type 1 phosphatases (Fig. 1) . The pnitrophenyl phosphate phosphatase activity of type 2B phosphatase (calcineurin) has nearly the same susceptibility to okadaic acid as its PMLC phosphatase activity (see also Fig. 2) . These results support the idea that the inhibitory action of okadaic acid is enzyme-directed.
The affinity of okadaic acid differs remarkably among the okadaic acid-sensitive phosphatases. The catalytic subunit of skeletal-muscle type 2A phosphatase (type 2AJ) is about 200 times more strongly inhibited by okadaic acid than is that of type 1 phosphatase, although there is a striking sequence homology between these catalytic subunits (Berndt et al., 1987) . The three-dimensional conformation of the enzyme molecule may be an important factor for the binding of okadaic acid. The aortic PCM phosphatase is a polymolecular enzyme consisting of three subunits, and belongs to the category of type 2A phosphatases (see the Experimental section). This phosphatase is considerably less susceptible to okadaic acid than is type 2A, phosphatase (Fig. 1) . The reason for this difference is not clear from the present results. It may imply that the aortic PCM phosphatase has a different catalytic subunit from that of the skeletalmuscle type 2A phosphatase. Another possibility is that the non-catalytic subunits make the catalytic subunit less accessible to okadaic acid.
The present kinetic study has shown that okadaic acid acts as a non-competitive or mixed inhibitor of the okadaic acid-sensitive enzymes, suggesting that the binding site for okadaic acid is different from that for the substrate. However, the reaction mechanism is likely to be more complicated. The Hill coefficients of doseinhibition relations tend to be smaller than 1 even after the correction for the higher extent of substrate consumption at lower inhibitor concentrations (see the Experimental section). When the Hill coefficient is not 1, the inhibition is not 'linear' according to Cleland's (1963) classification of enzyme inhibition (see Bialojan et al., 1988 ). In the model of ordinary (linear) inhibition, the constants K1 and K2 denote the dissociation constants of inhibitor for free enzyme and enzyme-substrate respectively (see Dixon & Webb, 1979 To our knowledge, okadaic acid is the first-described potent substance that inhibits type 2 phosphatases as well as type 1 phosphatase. The inhibition of phosphatase is reversible, as judged from its effects on myosin lightchain phosphorylation (Bialojan et al., 1988) . Therefore okadaic acid may serve as a unique tool for analysing phosphorylation-regulated systems.
